Publication | Closed Access

Phase II trial of cetuximab in the treatment of persistent or recurrent squamous or non-squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study

Cervical Cancer ManagementCervical CancerPhase Ii TrialNon-squamous Cell CarcinomaMedicineCancer ManagementGynecologyCancer TreatmentPublic HealthOncologyRadiation OncologyGynecology Oncology